Hambrecht & Quist Capital Management as of Dec. 31, 2011
Portfolio Holdings for Hambrecht & Quist Capital Management
Hambrecht & Quist Capital Management holds 71 positions in its portfolio as reported in the December 2011 quarterly 13F filing
Company (Ticker) |
Portfolio Weight |
Valued At |
Change in Shares |
Share Count |
Share Price |
---|---|---|---|---|---|
Pharmasset | 8.3 | $39M | 307k | 128.20 | |
Gilead Sciences (GILD) | 4.8 | $23M | 560k | 40.93 | |
Alexion Pharmaceuticals | 4.4 | $21M | 293k | 71.50 | |
Teva Pharmaceutical Industries (TEVA) | 4.0 | $19M | 476k | 40.36 | |
Perrigo Company | 3.7 | $18M | 182k | 97.30 | |
Akorn | 3.4 | $16M | 1.5M | 11.12 | |
Celgene Corporation | 3.2 | $15M | 223k | 67.60 | |
Mylan | 2.9 | $14M | 634k | 21.46 | |
Shire | 2.6 | $13M | 121k | 103.90 | |
Alkermes (ALKS) | 2.3 | $11M | 641k | 17.36 | |
Vertex Pharmaceuticals Incorporated (VRTX) | 2.3 | $11M | 331k | 33.21 | |
Biogen Idec (BIIB) | 2.3 | $11M | 100k | 110.05 | |
Aetna | 2.3 | $11M | 256k | 42.19 | |
Merck & Co (MRK) | 2.3 | $11M | 287k | 37.70 | |
Gen-Probe Incorporated | 2.2 | $11M | 181k | 59.12 | |
Neurocrine Biosciences (NBIX) | 2.2 | $10M | 1.2M | 8.50 | |
United Therapeutics Corporation (UTHR) | 2.2 | $10M | 219k | 47.25 | |
PerkinElmer (RVTY) | 1.8 | $8.6M | 428k | 20.00 | |
Allergan | 1.8 | $8.5M | 97k | 87.74 | |
Medivation | 1.8 | $8.5M | 184k | 46.11 | |
Cubist Pharmaceuticals | 1.6 | $7.9M | 199k | 39.62 | |
Express Scripts | 1.5 | $7.3M | 164k | 44.69 | |
Warner Chilcott Plc - | 1.5 | $7.3M | 481k | 15.13 | |
Onyx Pharmaceuticals | 1.5 | $7.2M | 164k | 43.95 | |
iShares NASDAQ Biotechnology Index (IBB) | 1.5 | $7.0M | 67k | 104.34 | |
PAREXEL International Corporation | 1.3 | $6.3M | 303k | 20.74 | |
Cerner Corporation | 1.3 | $6.2M | 101k | 61.25 | |
Elan Corporation | 1.3 | $6.0M | 440k | 13.74 | |
Impax Laboratories | 1.2 | $5.9M | 294k | 20.17 | |
Inhibitex | 1.2 | $6.0M | 544k | 10.94 | |
Amgen (AMGN) | 1.2 | $5.9M | 92k | 64.20 | |
Nektar Therapeutics (NKTR) | 1.2 | $5.7M | 1.0M | 5.59 | |
Dendreon Corporation | 1.2 | $5.6M | 735k | 7.60 | |
UnitedHealth (UNH) | 1.1 | $5.5M | 108k | 50.68 | |
Human Genome Sciences | 1.1 | $5.3M | 719k | 7.39 | |
Quest Diagnostics Incorporated (DGX) | 1.1 | $5.2M | 90k | 58.06 | |
Ariad Pharmaceuticals | 1.0 | $4.9M | 402k | 12.25 | |
Medco Health Solutions | 1.0 | $4.8M | 86k | 55.90 | |
IDEXX Laboratories (IDXX) | 1.0 | $4.8M | 63k | 76.96 | |
Zimmer Holdings (ZBH) | 1.0 | $4.8M | 89k | 53.42 | |
Amarin Corporation (AMRN) | 0.9 | $4.5M | 601k | 7.49 | |
McKesson Corporation (MCK) | 0.9 | $4.4M | 57k | 77.91 | |
CVS Caremark Corporation (CVS) | 0.9 | $4.3M | 106k | 40.78 | |
Intellipharmaceuticsintl Inc C | 0.9 | $4.3M | 1.6M | 2.74 | |
Baxter International (BAX) | 0.9 | $4.2M | 85k | 49.48 | |
Thermo Fisher Scientific (TMO) | 0.7 | $3.2M | 71k | 44.97 | |
Momenta Pharmaceuticals | 0.7 | $3.1M | 179k | 17.39 | |
Regeneron Pharmaceuticals (REGN) | 0.6 | $3.0M | 54k | 55.43 | |
Vivus | 0.6 | $2.9M | 299k | 9.75 | |
Bruker Corporation (BRKR) | 0.6 | $2.9M | 230k | 12.42 | |
Santarus | 0.6 | $2.8M | 854k | 3.31 | |
Affymax (AFFY) | 0.5 | $2.3M | 352k | 6.61 | |
Keryx Biopharmaceuticals | 0.4 | $2.1M | 812k | 2.53 | |
NPS Pharmaceuticals | 0.4 | $2.1M | 312k | 6.59 | |
Auxilium Pharmaceuticals | 0.4 | $2.0M | 100k | 19.93 | |
Acorda Therapeutics | 0.4 | $2.0M | 84k | 23.85 | |
Illumina (ILMN) | 0.4 | $1.8M | 58k | 30.49 | |
Zogenix | 0.3 | $1.6M | 725k | 2.24 | |
Jazz Pharmaceuticals | 0.3 | $1.5M | 39k | 38.63 | |
Addus Homecare Corp (ADUS) | 0.3 | $1.5M | 432k | 3.57 | |
Hca Holdings (HCA) | 0.3 | $1.3M | 60k | 22.04 | |
LifePoint Hospitals | 0.2 | $1.1M | 31k | 37.16 | |
OncoGenex Pharmaceuticals | 0.2 | $1.1M | 93k | 11.74 | |
Palomar Medical Technologies | 0.2 | $1.0M | 113k | 9.30 | |
Health Management Associates | 0.2 | $1.0M | 138k | 7.37 | |
Community Health Systems (CYH) | 0.2 | $975k | 56k | 17.46 | |
Cornerstone Therapeutics | 0.2 | $976k | 174k | 5.60 | |
Curis | 0.2 | $874k | 187k | 4.68 | |
Corcept Therapeutics Incorporated (CORT) | 0.2 | $855k | 250k | 3.42 | |
Aegerion Pharmaceuticals | 0.2 | $778k | 47k | 16.73 | |
Sanofi Aventis Wi Conval Rt | 0.0 | $124k | 104k | 1.20 |